Appeal No. 2003-0865 Page 2
Application No. 09/300,789
ii) administering to said individual an amount of a nonsteroidal anti-
inflammatory agent sufficient to effect said prevention or delay; and
iii) monitoring said individual for the development of clinical symptoms of
said disease or disorder.
11. A method of preventing or delaying the onset of Alzheimer's disease
or related neurodegenerative disorder. The method comprises:
i) identifying an individual at risk of developing
the disease or disorder;
ii) administering to the individual an amount of a
histamine H2 receptor blocking agent sufficient to effect
the prevention or delay; and
iii) monitoring the individual for the development of
clinical symptoms of the disease or disorder.
23. A method of preventing or delaying the onset of Alzheimer's disease
or related neurodegenerative disorder comprising:
i) identifying an individual at risk of developing the disease or disorder;
ii) administering to the individual an amount of an agent that inhibits
excitotoxic neuronal cell death sufficient to effect the prevention or delay; and
iii) monitoring the individual for the development of clinical symptoms of
said disease or disorder.
The examiner does not rely on any references.
Claims 1-23 and 26 stand rejected under 35 U.S.C. § 101 as lacking
utility, and claim 23 stands rejected under 35 U.S.C. § 112, first paragraph, as
nonenabled.
We reverse both rejections.
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007